Cita APA

DeRyckere, D., Lee-Sherick, A. B., Huey, M. G., Hill, A. A., Tyner, J. W., Jacobsen, K. M., . . . Graham, D. K. (2016). UNC2025, a MERTK small molecule inhibitor, is therapeutically effective alone and in combination with methotrexate in leukemia models. Clin Cancer Res.

Chicago Style Citation

DeRyckere, Deborah, et al. "UNC2025, a MERTK Small Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination With Methotrexate in Leukemia Models." Clin Cancer Res 2016.

Cita MLA

DeRyckere, Deborah, et al. "UNC2025, a MERTK Small Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination With Methotrexate in Leukemia Models." Clin Cancer Res 2016.